Impact of Delay of Treatment With Disease‐Modifying Antirheumatic Drugs in Psoriatic Arthritis: The CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

Impact of Delay of Treatment With Disease‐Modifying Antirheumatic Drugs in Psoriatic Arthritis: The CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

Objective Our objective was to describe characteristics and compare clinical and patient‐reported outcomes (PROs) for disease‐modifying antirheumatic drug (DMARD)–naive patients with psoriatic arthritis (PsA) who initiate DMARD therapy early versus late. Methods Patients with PsA from the CorEvitas...

Full description

Saved in:
Bibliographic Details
Main Authors: Philip J. Mease, Miroslawa Nowak, Jiyoon Choi, Thomas Lehman, Antoine Sreih, Kaylee Ho, Nicole Middaugh, Alexis Ogdie
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:ACR Open Rheumatology
Online Access:https://doi.org/10.1002/acr2.70019
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items